Showing results (381-390 of 950) with videos related to

Sort By:
Pageof 95
Cancer Research|April 15, 1993
Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell linesC Rowlands, V Krishnan, X Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center studyJ M Dixon, L Renshaw, C Bellamy, et al.
British Journal of Cancer|March 16, 2006
Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozoleW R Miller, S White, J M Dixon, et al.
Endocrine-Related Cancer|August 23, 2005
Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experienceW R Miller, T J Anderson, S White, et al.
Addiction (Abingdon, England)|May 1, 1997
Are reconstructed self-reports of drinking reliable?K A Grant, L T Arciniega, J S Tonigan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymesA D Ramage, S P Langdon, A A Ritchie, et al.
International Journal of Cancer|June 22, 1995
c-erbB growth-factor-receptor proteins in ovarian tumoursB J Simpson, H A Phillips, A M Lessells, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Zinc alpha-2 glycoprotein levels in serum and breast fluids: a potential marker of apocrine activityN J Bundred, W N Scott, S J Davies, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 2001
Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitorsA S Bhatnagar, A M Brodie, B J Long, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancerN J Bundred, H J Stewart, D A Shaw, et al.
Pageof 95